<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02011659</url>
  </required_header>
  <id_info>
    <org_study_id>PONV-NHIS-GYN-001</org_study_id>
    <nct_id>NCT02011659</nct_id>
  </id_info>
  <brief_title>Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy</brief_title>
  <acronym>PONV</acronym>
  <official_title>A Randomized Prospective Study of Scheduled Intravenous Ramosetron for the Prevention of Nausea and Vomiting in Hospitalized Patients After Gynecologic Laparoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Health Insurance Service Ilsan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Health Insurance Service Ilsan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare postoperative nausea and vomiting (PONV) and perioperative outcomes of gynecologic
      patients undergoing laparoscopic surgery after scheduled administration of intravenous
      Ramosetron during hospital stays.

        -  Randomized controlled arm : Placebo versus Ramosetron injection

        -  Administration schedule : immediate postoperative status, 12 hrs after surgery, 36hrs
           after surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surgical outcomes including operative time, blood loss, Hb change, postoperative pain,
      nausea/vomiting scale, times of rescue therapy, and complications
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence or intensity of PONV</measure>
    <time_frame>during postoperative hospital stays (2 days)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse reaction associated with Ramosetron injection</measure>
    <time_frame>Postoperatvie 7 days (at OPD based)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Uterine Myoma, Ovary Neoplasm, Adenomyosis</condition>
  <arm_group>
    <arm_group_label>Ramosetron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ramosetron</intervention_name>
    <arm_group_label>Ramosetron</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 18&lt; or =, = or &lt;70 with benign gynecologic disease

          -  ASA-Class I-II

          -  No-definite malignancy by US, CT/MRI, CA 125 &lt; 500IU/ml

          -  Non-smoker

        Exclusion Criteria:

          -  Conversion to laparotomy

          -  Hx of malignancy

          -  Smoker

          -  Suspicious malignancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>San-Hui Lee, M.D.</last_name>
    <phone>+82-900-0218</phone>
    <email>sanaram@naver.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Health Insurance Service Ilsan Hospital</name>
      <address>
        <city>Goyang-si</city>
        <zip>410-719</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>San-Hui Lee, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2013</study_first_submitted>
  <study_first_submitted_qc>December 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2013</study_first_posted>
  <last_update_submitted>December 12, 2013</last_update_submitted>
  <last_update_submitted_qc>December 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Health Insurance Service Ilsan Hospital</investigator_affiliation>
    <investigator_full_name>San-Hui Lee</investigator_full_name>
    <investigator_title>Clinical assistant professor</investigator_title>
  </responsible_party>
  <keyword>Ramosetron, postoperative nausea and vomiting, laparoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Adenomyosis</mesh_term>
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ramosetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

